Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/10/2010WO2010100650A2 Therapeutic uses of mastic gum fractions
09/10/2010WO2010100619A1 Metadoxine for use as inhibitor of hepatic fibrosis
09/10/2010WO2010100606A1 Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
09/10/2010WO2010100512A1 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for them preparation
09/10/2010WO2010100431A1 Pyrrolopyrimidines used as kinase inhibitors
09/10/2010WO2010100414A1 Abuse resistant formulation
09/10/2010WO2010100405A1 Triazine derivatives as kinase inhibitors
09/10/2010WO2010100404A2 Rna molecules and therapeutic uses thereof
09/10/2010WO2010100381A1 Novel antiviral agent
09/10/2010WO2010100337A1 Novel prodrugs of metformin
09/10/2010WO2010100312A1 Neuroprotective compounds
09/10/2010WO2010100297A1 Bisthiazole compounds that can be used to treat cancer
09/10/2010WO2010100255A1 Pharmaceutical hypocholesterolemic compositions
09/10/2010WO2010100252A1 Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail
09/10/2010WO2010100249A1 3h-imidazo [4, 5 -c] pyridine- 6 -carboxamides as anti- inflammatory agents
09/10/2010WO2010100248A1 Use of pyrimidylaminobenzamide derivatives for the treatment of disorders mediated by the leucine zipper- and sterile alpha motif-containing kinase (zak)
09/10/2010WO2010100247A1 Novel therapy for anxiety
09/10/2010WO2010100218A1 Cationic oil-in-water emulsions containing prostaglandins and uses thereof
09/10/2010WO2010100217A1 Anionic oil-in-water emulsions containing prostaglandins and uses thereof
09/10/2010WO2010100207A1 Pharmaceutical compositions of active pharmaceutical ingredient comprising sulphonylurea moiety with excellent dissolution properties
09/10/2010WO2010100199A1 Fluconazole carboxylic ester derivatives, synthesis, and use in long acting formulations
09/10/2010WO2010100186A1 Fluconazole carboxylic ester derivatives, synthesis, and use in long acting formulations
09/10/2010WO2010100178A1 Heterocyclic antiviral compounds
09/10/2010WO2010100144A1 Fused bicyclic compounds as inhibitors for pi3 kinase
09/10/2010WO2010100142A1 Oxazole pyridine derivatives useful as s1p1 receptor agonists
09/10/2010WO2010100139A1 Derivatives of benzothiazines, preparation thereof and application thereof as drugs
09/10/2010WO2010100133A2 Indole derivatives for treating neurodegenerative diseases
09/10/2010WO2010100127A1 Disubstituted imidazole derivatives as modulators of raf kinase
09/10/2010WO2010100070A1 Inhibitors of bruton's tyrosine kinase
09/10/2010WO2010100063A1 Topical pharmaceutical composition comprising an antiseptic and arginine for wound healing
09/10/2010WO2010100060A2 Method for increasing endogenous plasmalogen levels in mammals
09/10/2010WO2010100050A1 Pyridine-2-yl-carboxylic acid amides
09/10/2010WO2010099938A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
09/10/2010WO2010099740A1 13a-(s) desoxytylophorinine derivatives, preparation method, pharmaceutical compositon and use thereof
09/10/2010WO2010099731A1 Compounds, compositions and use for anticancer therapy
09/10/2010WO2010099698A1 Salts of tetrahydroimidazo [1,5-a] pyrazine derivatives, preparation methods and pharmaceutical use thereof
09/10/2010WO2010099601A1 Use of 5ahq and bortezomib for the treatment of hematological diseases
09/10/2010WO2010099600A1 Compounds and methods for treating cancer and viral infections
09/10/2010WO2010099587A1 Medicinal cosmetic lipoatrophy
09/10/2010WO2010099573A1 Dioxolane norbornane / norbornene compounds suitable as antimicrobial agents to treat bacterial infections
09/10/2010WO2010083441A3 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
09/10/2010WO2010083162A3 Unc-45a splice variants based cancer diagnostics and therapeutics
09/10/2010WO2010081781A4 Energetic nutritional composition comprising a laxative, electrolytes and carbohydrates
09/10/2010WO2010079506A3 Pharmaceutical composition of aripiprazole
09/10/2010WO2010078916A4 Immunocytokines for tumour therapy with chemotherapeutic agents
09/10/2010WO2010076812A4 Topical herbal formulation for treatment of acne and skin disorders
09/10/2010WO2010075765A9 Cefdinir acid double salt and its preparation
09/10/2010WO2010067986A3 Composition for controlling gastrointestinal tract movement
09/10/2010WO2010064139A3 Zaleplon gastroretentive drug delivery system
09/10/2010WO2010062996A3 Ribavirin composition
09/10/2010WO2010062147A3 Crystal form of adefovir dipivoxil, preparation method thereof, and pharmaceutical composition containing the same
09/10/2010WO2010059943A3 Fluorination of organic compounds
09/10/2010WO2010059372A3 Tryptase enzyme inhibiting aminopyridines
09/10/2010WO2010059004A3 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient
09/10/2010WO2010059001A3 Polymer micelle composition for treatment of resistant cancer cells
09/10/2010WO2010055419A3 A method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosclerosis
09/10/2010WO2010054336A3 Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
09/10/2010WO2010053316A3 New use of sixth immunoglobulin-like domain of vcam-1
09/10/2010WO2010052448A3 Fused pyrazine derivatives as kinase inhibitors
09/10/2010WO2010050783A3 Novel compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same
09/10/2010WO2010048549A3 5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom
09/10/2010WO2010048446A3 Modulation of axon degeneration
09/10/2010WO2010042163A3 Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
09/10/2010WO2010041279A4 Sustained release drug delivery system
09/10/2010WO2010041015A3 Chewable gelled emulsions
09/10/2010WO2010032041A3 Antibacterial and/or anti-acne formulations containing salicylic acid or a derivative thereof
09/10/2010WO2009117316A3 Pharmaceutical compositions having desirable bioavailability
09/10/2010WO2009116067A3 Novel derivatives of acyl cyanopyrrolidines
09/10/2010WO2009106997A3 Amorphous arformoterol l-(+)-tartrate
09/10/2010WO2009104205A8 Delayed release formulation of chloride channel activator
09/10/2010WO2009094668A8 New 2,3,4,5-tetrahydro-1h-pyrido[ 4,3-b] indole compounds and methods of use thereof
09/10/2010WO2009089422A3 Inhalation drug products, systems and uses
09/10/2010WO2009070609A3 Therapeutic targeting of il-6 using sirna in neutral liposomes
09/10/2010WO2009068531A3 Adamantyl o-glucuronide derivatives as inhibitors of dipeptidyl peptidase iv for the treatment of diabetes
09/10/2010WO2009056292A9 Osmolyte-containing preparation for use in case of dry mucous membranes
09/10/2010CA2754840A1 Methods of enhancing peroxide activity
09/10/2010CA2754834A1 Kinase protein binding inhibitors
09/10/2010CA2754655A1 Novel antiviral agent
09/10/2010CA2754564A1 Therapeutic uses of mastic gum fractions
09/10/2010CA2754549A1 Enhancing coagulation or reducing fibrinolysis
09/10/2010CA2754457A1 Quinoxaline compounds
09/10/2010CA2754446A1 Pyridine derivative
09/10/2010CA2754384A1 Pharmaceutical hypocholesterolemic compositions
09/10/2010CA2754330A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
09/10/2010CA2754283A1 Indole derivatives for treating neurodegenerative diseases
09/10/2010CA2754226A1 Method and material for site activated complexing of biologic molecules
09/10/2010CA2754203A1 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
09/10/2010CA2754157A1 Cationic oil-in-water emulsions containing prostaglandins and uses thereof
09/10/2010CA2754156A1 Anionic oil-in-water emulsions containing prostaglandins and uses thereof
09/10/2010CA2754089A1 Pharmaceutical composition containing 1h-inden-1-amine, 2,3-dihydro-n-2-propynyl-, (1r)-, methanesulfonate
09/10/2010CA2754075A1 Cholestanol derivative for combined use
09/10/2010CA2754058A1 8-substituted quinolines and related analogs as sirtuin modulators
09/10/2010CA2754008A1 Medicinal cosmetic lipoatrophy
09/10/2010CA2753972A1 Imidazole derivatives useful as modulators of faah and as faah imaging agents
09/10/2010CA2753947A1 Non-steroidal anti-inflammatory ophthalmic compositions
09/10/2010CA2753862A1 Tetrahydro-imidazo[1,5-.alpha.]pyrazine derivatives salts, preparation methods and medicinal use thereof
09/10/2010CA2753860A1 Oral dosage forms having a high loading of a gabapentin prodrug
09/10/2010CA2753847A1 Methods for treating ocular inflammatory diseases
09/10/2010CA2753730A1 Inhibitors of beta-secretase
09/10/2010CA2753703A1 Nucleic acid complex and nucleic acid-delivering composition
1 ... 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 ... 7860